Literature DB >> 9013480

Enhanced effects of multiple treatment electrochemotherapy.

M J Jaroszeski1, R Gilbert, R Perrott, R Heller.   

Abstract

Electrochemotherapy has been demonstrated to be an effective treatment for cutaneous cancers. The treatment includes administering a chemotherapeutic agent followed by electric pulses which are applied directly to the tumour. The pulses facilitate delivery of drug through the plasma membrane. Enhanced delivery is restricted to the area that has been electrically treated. Currently, electrochemotherapy is administered as a single treatment. Complete response rates are high; however, partial responses are obtained in a fraction of the treated tumours. An issue associated with this is whether or not multiple treatments would result in an improved therapy for these partially responding tumours. A multiple treatment electrochemotherapy study was implemented in order to address this issue. The study utilized subcutaneously induced murine B16 melanoma tumours in C57B1/6 mice. Results showed large tumour volume reductions in multiple treatment groups. In addition, a twofold increase in tumour doubling time and greater percentages of complete responses were found as a result of multiple treatment. These results will be utilized to augment existing clinical trials with respect to retreating tumours that have partially responded to a single electrochemotherapy treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9013480     DOI: 10.1097/00008390-199612000-00004

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  3 in total

1.  Electroporation driven delivery of both an IL-12 expressing plasmid and cisplatin synergizes to inhibit B16 melanoma tumor growth through an NK cell mediated tumor killing mechanism.

Authors:  Ha Kim; Jeong-Im Sin
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

2.  Bioelectric applications for treatment of melanoma.

Authors:  Stephen J Beebe; Karl H Schoenbach; Richard Heller
Journal:  Cancers (Basel)       Date:  2010-09-27       Impact factor: 6.639

3.  Combined local and systemic bleomycin administration in electrochemotherapy to reduce the number of treatment sessions.

Authors:  Felipe Maglietti; Matias Tellado; Nahuel Olaiz; Sebastian Michinski; Guillermo Marshall
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.